Evidence map›Paper›PMID 11518722›Full record

ReviewThe Journal of clinical investigation2001

The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

G Duncan, C McCormick, F Tufaro

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Perspectives in membranous nephropathy.Cell and tissue research · 2021
    Review
  18. New 'Antigens' in Membranous Nephropathy.Journal of the American Society of Nephrology : JASN · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

G DuncanDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
C McCormick
F Tufaro
University of British Columbia · CAUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genes, Tumor SuppressorAcetylglucosamineAdultAnimalsBiopolymersBone DevelopmentBone NeoplasmsCartilageChildCHO CellsCricetinaeDNA Mutational AnalysisEvolution, MolecularExostoses, Multiple HereditaryExostosin 1Exostosin 2AcetylglucosamineBiopolymersExostosin 1Exostosin 2Glucuronic AcidHeparan SulfateMacromolecular SubstancesN-AcetylglucosaminyltransferasesParathyroid Hormone-Related ProteinProteinsPTHLH protein, humanReceptor, Parathyroid Hormone, Type 1Receptors, Parathyroid Hormone

Identifiers

PMID11518722
PMCPMC209410
OpenAlexW1977576363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.